Related Experiment Videos
Sympathetic skin response: correlation with autonomic and somatic involvement in multiple sclerosis
A B Caminero1, A Pérez-Jiménez, P Barreiro
1Department of Neurology, Hospital La Paz, Madrid, Spain.
Summary
Sympathetic skin response (SSR) testing in multiple sclerosis (MS) patients revealed abnormalities in 41%, correlating with disability. While useful for monitoring MS progression and detecting subclinical lesions, SSR has limited diagnostic value for autonomic dysfunction.
Area of Science:
- Neurology
- Autonomic Nervous System Function
- Clinical Neurophysiology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease affecting the central nervous system.
- Autonomic dysfunction is a common complication in MS, impacting various bodily functions.
- The sympathetic skin response (SSR) is a measure of sympathetic sudomotor function.
Purpose of the Study:
- To investigate the utility of SSR testing in evaluating patients with multiple sclerosis.
- To assess the correlation between SSR abnormalities and clinical disability in MS.
- To determine the diagnostic value of SSR for autonomic dysfunction in MS.
Main Methods:
- SSR was recorded from palms and soles in 63 MS patients (54 definite, 9 probable) using electric stimuli.
- Patients were assessed using the Kurtzke Expanded Disability Status Scale (EDSS).
- Comparisons were made with other evoked potentials (VEP, BAEP, SEP) and signs of autonomic dysfunction (bladder impairment).
Main Results:
- Abnormal SSR (absent or delayed) was found in 41% of MS patients.
- Abnormal SSR correlated positively with higher EDSS scores and increased latencies.
- Bladder impairment was the most frequent autonomic dysfunction associated with altered SSR.
- Visual evoked potentials showed a positive correlation with SSR abnormalities.
Conclusions:
- SSR is a simple test for dynamic evaluation in MS, correlating with disability and detecting subclinical sympathetic lesions.
- SSR has limited localizing value and low sensitivity for bladder-related autonomic impairment.
- SSR is not a primary diagnostic tool for MS but can aid in monitoring disease progression.